7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiomyopathies
The term cardiomyopathy refers to a variety of conditions in which the heart muscle becomes weakened or abnormally thickened, affecting its ability to pump blood effectively. Cardiomyopathies can be either inherited or acquired, with genetic mutations often playing a significant role in conditions like hypertrophic cardiomyopathy. As these diseases progress, they may lead to arrhythmias or heart failure, making early intervention crucial. Management strategies typically involve a combination of medications, lifestyle adjustments, and monitoring to prevent complications. In some cases, patients may require devices like pacemakers or even a heart transplant. With greater awareness and advancements in treatment, cardiomyopathies are becoming more manageable, offering hope for affected individuals.
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States, United States
Federico Benetti
Benetti Foundation, Argentina
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Syed Raza
Awali Hospital, Bahrain
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States
Title : Nanoantibiotics: An emerging strategy to combat antimicrobial resistance in cardiovascular infections
Zareena Ali, The Women University Multan, Pakistan
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina